A good patient experience starts with a good first impression, and Assort Health just closed $76M of Series B funding to prove its AI agents can deliver exactly that.
Accessing care is a painful process. The Assort OS platform delivers AI agents that can help manage patients’ needs, give staff more bandwidth for higher-level tasks, and reduce friction (AKA frustration) for everyone involved.
- The agents go beyond scheduling, handling everything from care navigation and prescription renewals to physician referrals and lab tests.
Goodbye hold music, hello agents. Providers have less staff to manage more patients, so they’re desperately looking for ways to offload the burden on the front office. Voice agents have become the go-to solution, and it’s tough to stand out.
Assort lists several core features that separate it from the pack:
- Specialty-specific agents – PCPs and oncologists aren’t asking patients the same questions, and Assort adapts to the unique needs of each specialty.
- Seamless integration – Assort’s agents integrate directly into the EHR and practice management systems, allowing them to work within the unique clinical rules and workflows of each provider.
- 90% resolution rate – The specialty-specific tuning allows Assort’s agents to maintain a resolution rate above 90%, while limiting errors like misdirected referrals.
Momentum builds momentum. There might be a ton of startups jumping into the voice AI arena, but not many are closing a Series B less than four months after their Series A.
- Assort’s investors will tell you that it’s “leading the re-platforming of patient engagement into the AI-native era.” At least they’re putting their money where their mouth is.
- Assort now plans to use the $102M it’s raised over the last four months to get its agents into as many practices as possible before the competition gets their first.
The Takeaway
The race is on to transform the patient experience with the magic of AI, and Assort might just have enough agents (and VC dollars) to pull a rabbit out of its hat.
